CEDRUS’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$360K Buy
774
+120
+18% +$55.8K 0.13% 124
2024
Q2
$307K Sell
654
-42
-6% -$19.7K 0.15% 120
2024
Q1
$291K Sell
696
-95
-12% -$39.7K 0.16% 121
2023
Q4
$322K Buy
+791
New +$322K 0.2% 114